Are biosimilars the next tool to guarantee cost-containment for pharmaceutical expenditures?

Overview of attention for article published in HEPAC Health Economics in Prevention and Care, November 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
Good Attention Score compared to outputs of the same age and source (76th percentile)

So far, Altmetric has seen 5 X posts from 4 X users, with an upper bound of 13,344 followers.

Are #biosimilars the next tool to guarantee cost-containment for pharmaceutical expenditures http://t.co/TVc3AyjEeJ

Are #biosimilars the next tool to guarantee cost-containment for pharmaceutical expenditures http://t.co/TVc3AyjEeJ

Are #biosimilars the next tool to guarantee cost-containment for pharmaceutical expenditures http://t.co/TVc3AyjEeJ

Are biosimilars the next tool to guarantee cost-containment for pharmaceutical expenditures? https://t.co/zXvkPJF6rC

Are biosimilars the next tool to guarantee cost-containment for pharmaceutical expenditures? http://t.co/TtWHd6Pn8S